CorMedix Inc.
300 Connell Drive, Suite 4200
Berkeley Heights, NJ 07922
August 18, 2021
VIA EDGAR TRANSMISSION
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Ada D. Sarmento, Attorney-Advisor
| Re: | CorMedix Inc. | |
| Registration Statement on Form S-3 | ||
| Filed August 12, 2021 | ||
| File No. 333-258756 |
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, CorMedix Inc. (the “Company”), hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333- 258756), so that such registration statement may become effective at 3:00 p.m. (Washington, D.C. time) on August 20, 2021, or as soon as practicable thereafter.
| CORMEDIX INC. | |||
| By: | /s/ Khoso Baluch | ||
| Name:Khoso Baluch | |||
| Title:Chief Executive Officer | |||
